Metro-Minnesota CCOP — Saint Louis Park, Minnesota

Metro-Minnesota CCOP is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Metro-Minnesota CCOP has participated in 30 clinical trials with 2 currently active.

Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Sponsors: National Cancer Institute (NCI), NSABP Foundation Inc, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-Minnesota CCOP?

Metro-Minnesota CCOP has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-Minnesota CCOP conducted?

Metro-Minnesota CCOP has 30 clinical trials on record, with 2 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Is Metro-Minnesota CCOP accredited by Crixeo Health?

Yes — Metro-Minnesota CCOP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Metro-Minnesota CCOP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.